Newspaper Publication of unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals Ltd has submitted copies of newspaper advertisements containing its unaudited financial results for the quarter and nine months ended December 31, 2025. The ads were published on Saturday, February 14, 2026 in the English newspaper 'Financial Express' (nationwide circulation) and the Kannada vernacular paper 'Hosa Digantha', as required under SEBI's Listing Regulations. This is a routine compliance submission to BSE (Scrip: PHARMAID, Code: 524572) under Regulation 30 and 47. The detailed financial numbers in the underlying newspaper clippings appear garbled/unreadable in the filing, so actual revenue, profit or loss figures cannot be extracted from this document.
This is a regulatory housekeeping filing rather than a fresh business announcement, so no direct price catalyst is expected. Investors wanting the real Q3 FY26 numbers should look at the detailed unaudited results already filed with BSE rather than relying on this newspaper notice.